跳至主要内容
临床试验/NCT00428129
NCT00428129终止2 期

An Open Label Clinical Trial of Microplasmin Administered Via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis

ThromboGenics1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2007年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
发起方
ThromboGenics
入组人数
6
试验地点
1
主要终点
Treatment success - treated segment has < 25% residual thrombus AND flow is present following administration of microplasmin

研究概览

简要总结

A single centre, single-arm study to evaluate safety and efficacy of microplasmin administration via the Trellis-8 Infusion System in patients with acute iliofemoral DVT

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

干预措施: microplasmin (Drug)

结局指标

主要结局

Treatment success - treated segment has < 25% residual thrombus AND flow is present following administration of microplasmin

时间窗: During intervention procedure

次要结局

  • Grade of lysis(Upon completion of procedure)
  • Limb patency(Baseline, 48h post procedure, Day-7 and Day-30)
  • Target limb reintervention(Day-7 and Day-30)
  • Clinical outcomes(Baseline, 48h post procedure, Day-7 and Day-30)

研究者

发起方
ThromboGenics
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Microplasmin Administered Via the Trellis-8 Infusion... | 临床试验